 |
PDBsum entry 4xqa
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Viral protein
|
PDB id
|
|
|
|
4xqa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Org Biomol Chem
13:9194-9205
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Triazole linker-based trivalent sialic acid inhibitors of adenovirus type 37 infection of human corneal epithelial cells.
|
|
R.Caraballo,
M.Saleeb,
J.Bauer,
A.M.Liaci,
N.Chandra,
R.J.Storm,
L.Frängsmyr,
W.Qian,
T.Stehle,
N.Arnberg,
M.Elofsson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Adenovirus type 37 (Ad37) is one of the principal agents responsible for
epidemic keratoconjunctivitis (EKC), a severe ocular infection that remains
without any available treatment. Recently, a trivalent sialic acid derivative
(ME0322, Angew. Chem. Int. Ed., 2011, 50, 6519) was shown to function as a
highly potent inhibitor of Ad37, efficiently preventing the attachment of the
virion to the host cells and subsequent infection. Here, new trivalent sialic
acid derivatives were designed, synthesized and their inhibitory properties
against Ad37 infection of the human corneal epithelial cells were investigated.
In comparison to ME0322, the best compound (17a) was found to be over three
orders of magnitude more potent in a cell-attachment assay (IC50 = 1.4 nM) and
about 140 times more potent in a cell-infection assay (IC50 = 2.9 nM). X-ray
crystallographic analysis demonstrated a trivalent binding mode of all compounds
to the Ad37 fiber knob. For the most potent compound ophthalmic toxicity in
rabbits was investigated and it was concluded that repeated eye administration
did not cause any adverse effects.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |